title: HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed.
abstract: HSVs transit from vigorous replication at the portal of entry into the body to a latent state in sensory neurons in which only noncoding (e.g., latency-associated transcript) and micro-RNAs are expressed. In productive infection, viral genes must be sequentially derepressed at two checkpoints. A leading role in the repression of viral genes is carried out by histone deacetylase (HDAC)/corepressor element-1 silencing transcription factor (CoREST)/lysinespecific demethylase1(LSD1)/RE1-silencing transcription factor (REST) repressor complex (HCLR). Previously, we reported that to define the role of the components of the HCLR complex in the establishment of latency, we constructed recombinant virus (R112) carrying a dominant-negative REST that bound response elements in DNA but could not recruit repressive proteins. This recombinant virus was unable to establish latency. In the current studies, we constructed a virus (R111) carrying WT REST with a WT genome. We report the following findings: (a) R111 readily established latent infection in trigeminal ganglia; however, although the amounts of viral DNAs in latently infected neurons were similar to those of WT virus, the levels of latency-associated transcript and micro-RNAs were 50- to 100-fold lower; (b) R111 did not spontaneously reactivate in ganglionic organ cultures; however, viral genes were expressed if the synthesis of REST was blocked by cycloheximide; and (c) histone deacetylase inhibitors reactivated the WT parent but not the R111 recombinant virus. The results suggest that REST plays a transient role in the establishment of latency but not in reactivation and suggest the existence of at least two phases at both establishment and reactivation.
authors: Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, IL 60637, USA.
authors: Guoying
authors: G
authors: Zhou
authors: Te
authors: T
authors: Du
authors: Bernard
authors: B
authors: Roizman
mesh_terms: D000818:Animals; D003513:Cycloheximide / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D005814:Genes, Viral; D018259:Herpesvirus 1, Human / Q000235:genetics* / Q000472:pathogenicity* / Q000502:physiology; D054884:Host-Pathogen Interactions / Q000235:genetics / Q000502:physiology; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D051379:Mice; D008808:Mice, Inbred CBA; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D012367:RNA, Viral / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012097:Repressor Proteins / Q000235:genetics* / Q000502:physiology*; D012668:Trigeminal Ganglion / Q000821:virology; D014775:Virus Activation / Q000235:genetics / Q000502:physiology; D017735:Virus Latency / Q000235:genetics / Q000502:physiology; D014779:Virus Replication / Q000235:genetics / Q000502:physiology; D000099229:RE1-Silencing Transcription Factor
chemical_list: D003513:Cycloheximide; D003907:Dexamethasone; D006877:Hydroxamic Acids; D035683:MicroRNAs; D012367:RNA, Viral; D011994:Recombinant Proteins; D012097:Repressor Proteins; D000099229:RE1-Silencing Transcription Factor; C477253:latency associated transcript, herpes simplex virus-1; C012589:trichostatin A